Insider Trading Alert - MLNX, HAE And ICE Traded By Insiders - TheStreet

Yesterday, Oct. 28, 2015, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $107,598,400.00.

Highlighted Stocks Traded by Insiders:

Mellanox Technologies (MLNX) - FREE Research Report

Kagan Michael, who is CTO & VP of Architecture at Mellanox Technologies, sold 2,000 shares at $46.56 on Oct. 28, 2015. Following this transaction, the CTO & VP of Architecture owned 165,063 shares meaning that the stake was reduced by 1.2% with the 2,000-share transaction.

The shares most recently traded at $47.61, up $1.05, or 2.21% since the insider transaction. Historical insider transactions for Mellanox Technologies go as follows:

  • 4-Week # shares bought: 57,739
  • 4-Week # shares sold: 2,374
  • 12-Week # shares bought: 57,739
  • 12-Week # shares sold: 2,374
  • 24-Week # shares bought: 57,739
  • 24-Week # shares sold: 11,874

The average volume for Mellanox Technologies has been 635,400 shares per day over the past 30 days. Mellanox Technologies has a market cap of $2.2 billion and is part of the technology sector and electronics industry. Shares are up 12.12% year-to-date as of the close of trading on Wednesday.

Mellanox Technologies, Ltd., a fabless semiconductor company, designs, manufactures, and sells interconnect products and solutions. The company has a P/E ratio of 51.3. Currently, there are 5 analysts who rate Mellanox Technologies a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MLNX - FREE

TheStreet Quant Ratings

rates Mellanox Technologies as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full

Mellanox Technologies Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Haemonetics (HAE) - FREE Research Report

Hanlon Susan M, who is VP Finance at Haemonetics, sold 497 shares at $32.13 on Oct. 28, 2015. Following this transaction, the VP Finance owned 20,464 shares meaning that the stake was reduced by 2.37% with the 497-share transaction.

Lindop Christopher J, who is CFO & EVP Business Development at Haemonetics, sold 436 shares at $32.13 on Oct. 28, 2015. Following this transaction, the CFO & EVP Business Development owned 45,350 shares meaning that the stake was reduced by 0.95% with the 436-share transaction.

White Jonathan, who is Chief Science and Technology at Haemonetics, sold 319 shares at $32.13 on Oct. 28, 2015. Following this transaction, the Chief Science and Technology owned 30,507 shares meaning that the stake was reduced by 1.03% with the 319-share transaction.

Jesse Sandra, who is EVP and Chief Legal Officer at Haemonetics, sold 778 shares at $32.13 on Oct. 28, 2015. Following this transaction, the EVP and Chief Legal Officer owned 20,096 shares meaning that the stake was reduced by 3.73% with the 778-share transaction.

Selman Byron, who is President, Global Markets at Haemonetics, sold 344 shares at $32.13 on Oct. 28, 2015. Following this transaction, the President, Global Markets owned 12,010 shares meaning that the stake was reduced by 2.78% with the 344-share transaction.

The shares most recently traded at $34.27, up $2.14, or 6.25% since the insider transaction. Historical insider transactions for Haemonetics go as follows:

  • 4-Week # shares sold: 1,380
  • 12-Week # shares sold: 1,380
  • 24-Week # shares sold: 4,044

The average volume for Haemonetics has been 319,400 shares per day over the past 30 days. Haemonetics has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are down 9.3% year-to-date as of the close of trading on Wednesday.

Haemonetics Corporation designs, manufactures, and markets blood management solutions. The company operates through North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific, and Japan segments. The company has a P/E ratio of 86.0. Currently, there are 3 analysts who rate Haemonetics a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAE - FREE

TheStreet Quant Ratings

rates Haemonetics as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, disappointing return on equity and weak operating cash flow. Get the full

Haemonetics Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

IntercontinentalExchange Group (ICE) - FREE Research Report

Hill Scott A, who is Chief Financial Officer at IntercontinentalExchange Group, sold 2,000 shares at $250.00 on Oct. 28, 2015. Following this transaction, the Chief Financial Officer owned 26,345 shares meaning that the stake was reduced by 7.06% with the 2,000-share transaction.

The shares most recently traded at $210.28, down $39.72, or 18.89% since the insider transaction. Historical insider transactions for IntercontinentalExchange Group go as follows:

  • 4-Week # shares sold: 500
  • 12-Week # shares sold: 500
  • 24-Week # shares sold: 500

The average volume for IntercontinentalExchange Group has been 967,000 shares per day over the past 30 days. IntercontinentalExchange Group has a market cap of $24.7 billion and is part of the financial sector and financial services industry.

Intercontinental Exchange, Inc. operates a network of regulated exchanges and clearing houses for financial and commodity markets in the United States, the United Kingdom, Continental Europe, Israel, Canada, and Singapore.

Exclusive Offer: Get the latest Stock Analysis on ICE - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.